David Bharucha
Director Técnico/Científico/I+D en MILESTONE PHARMACEUTICALS INC. .
Fortuna: 22 680 $ al 31/05/2024
Cargos activos de David Bharucha
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Director Técnico/Científico/I+D | 15/02/2022 | - |
Historial de carrera de David Bharucha
Antiguos cargos conocidos de David Bharucha.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ALLERGAN PLC | Corporate Officer/Principal | 01/01/2018 | 01/01/2021 |
Formación de David Bharucha.
| The University of Chicago | Doctorate Degree |
| Haverford College | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 3 |
| Canadá | 2 |
| Irlanda | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
- Bolsa de valores
- Insiders
- David Bharucha
- Experiencia
